Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Remdesivir Approved by FDA Experimental Antiviral Mar/05/2021 60 4
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 20 10
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/19/2021 6 2
CoronaVac Potential treatment - clinical evidence Experimental Vaccine Feb/03/2021 4 0
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
MVC-COV1901 Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020 2 0
C135-LS/C121-LS Potential treatment - pre-clinical evidence Experimental Antiviral Nov/19/2020 1 0